Palvella Therapeutics, Inc. (PVLA)
123.46
+3.08
(+2.56%)
USD |
NASDAQ |
Apr 02, 16:00
123.21
-0.25
(-0.20%)
After-Hours: 20:00
Palvella Therapeutics Market Cap : 1.809B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals, Inc. | 3.987B |
| Gossamer Bio, Inc. | 88.22M |
| Agenus, Inc. | 125.61M |
| Novavax, Inc. | 1.208B |
| Regeneron Pharmaceuticals, Inc. | 78.97B |
Market Cap Related Metrics
| Price to Book Value | 63.15 |
| Price | 123.46 |
| Earnings Yield | -3.00% |